Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Iradimed (IRMD) Receivables - Net (2016 - 2025)

Iradimed (IRMD) has disclosed Receivables - Net for 13 consecutive years, with $13.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Receivables - Net rose 33.71% to $13.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $13.9 million, a 33.71% increase, with the full-year FY2024 number at $10.6 million, down 13.64% from a year prior.
  • Receivables - Net was $13.9 million for Q3 2025 at Iradimed, up from $10.9 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $13.9 million in Q3 2025 to a low of $3.9 million in Q2 2021.
  • A 5-year average of $9.9 million and a median of $10.9 million in 2025 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: dropped 22.0% in 2021, then soared 158.43% in 2022.
  • Iradimed's Receivables - Net stood at $5.1 million in 2021, then skyrocketed by 158.43% to $13.3 million in 2022, then fell by 7.91% to $12.2 million in 2023, then decreased by 13.64% to $10.6 million in 2024, then surged by 31.27% to $13.9 million in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Receivables - Net are $13.9 million (Q3 2025), $10.9 million (Q2 2025), and $12.7 million (Q1 2025).